Back to search

Japan· JP-2119001F1019

エチレフリン塩酸塩

A etilefrine product containing エチレフリン塩酸塩, registered in Japan, on the national reimbursement list. The same ATC class is registered in 8 of our 19 countries.

On Japan’s NHI price listATC C01CA01

Checked against MHLW / PMDA (Japan) on

Informational only — not a medical device.

SOURCE REGISTER · JPMHLW / PMDA (Japan)normalisedエチレフリン塩酸塩ATCC01CA01REGISTER NO.JP-2119001F1019PACKS LISTED0CHECKEDSeptember 25, 2026

Where it is registered

Etilefrine is registered in 8 of 19 countries.

Countries holding a registration under ATC C01CA01 (etilefrine), each read from that country’s own register.

  • This record: Japan, from MHLW / PMDA (Japan)
  • 5 of them publish a price we can compare per daily dose

Etilefrine · ATC C01CA01

8 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Germany
  • Japan
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of etilefrine costs, country by country.

Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Etilefrine · price per daily dose (50 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.39
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

MHLW / PMDA (Japan)
Active substance
エチレフリン塩酸塩
Manufacturer
—
Country
Japan (JP)
ATC code
C01CA01
ATC class
Etilefrine
Defined daily dose
50 mg, O
Reimbursed
Yes
Source register
MHLW / PMDA (Japan)
Last checked
September 25, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df00789a-8ab8-4a90-b7df-779239ae9b69
GET /v1/drugs/df00789a-8ab8-4a90-b7df-779239ae9b69?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "spec": "5mg1錠",
  "marks": "局",
  "source": "mhlw",
  "remarks": null,
  "yj_code": "2119001F1019",
  "category": "内用薬",
  "price_yen": null,
  "generic_name": "エチレフリン塩酸塩",
  "product_name_jp": null,
  "therapeutic_class": "2119",
  "transitional_expiry": null
}

See everything about etilefrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.